NCT00040781View on ClinicalTrials.gov

Gefitinib in Treating Children With Refractory Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

June 30, 2002

Primary Completion Date

October 31, 2004

Conditions
Unspecified Childhood Solid Tumor, Protocol Specific
Interventions
DRUG

gefitinib

Given orally

OTHER

pharmacological study

Correlative studies

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (1)

91006-3776

Children's Oncology Group, Arcadia

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00040781 - Gefitinib in Treating Children With Refractory Solid Tumors | Biotech Hunter | Biotech Hunter